Loading asset research
Q2 2026 earnings · After close · Sep 25
Inventiva S.A. American Depository Shares
IVANasdaq · USD · StocksQuote as of · Exchange session not verified$4.02
-2.90%
Today
IVA
Loading 1D prices…
Market cap
$949.6M
Volume
1.7M
52w high
$7.9852w low
$3.35Company profile
Inventiva S.A. American Depository Shares
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Daix, France, United States
Employees
69
Fiscal year end
1231
CIK
1756594
Session & valuation
Open$4.25
Previous close$4.14
Day high$4.26
Day low$3.91
30-day avg. volume838.7K
Outstanding shares193.2M
Diluted EPS-$1.90
Latest annual period
P/E (trailing)-2.12
P/E (forward)-4.82
Price / book-23.45
Beta0.92
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| HELPCybin Inc. Common Stock | $947.6M | — | — | -$4.25 | +1.01% | Buy |
| FTHFaeth Therapeutics Inc. Common Stock | $967.5M | $0.00 | — | -$16.72 | -4.00% | Buy |
| ARDXArdelyx Inc. Common Stock | $924.3M | $407.3M | -15.22% | -$0.26 | -1.24% | Buy |
| ANLAdlai Nortye Group Ltd. American Depositary Shares | $979.5M | $5M | -710.56% | -$1.11 | +0.80% | Buy |
| DSGNDesign Therapeutics Inc. Common Stock | $915.6M | $0.00 | — | -$1.22 | -1.01% | Buy |